Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.thromres.2020.04.013

http://scihub22266oqcxt.onion/10.1016/j.thromres.2020.04.013
suck pdf from google scholar
32291094!7146714!32291094
unlimited free pdf from europmc32291094    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32291094  :  Publisher
PDF vom PMID32291094

suck abstract from ncbi

pmid32291094
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Incidence of thrombotic complications in critically ill ICU patients with COVID-19 #MMPMID32291094
  • Klok FA; Kruip MJHA; van der Meer NJM; Arbous MS; Gommers DAMPJ; Kant KM; Kaptein FHJ; van Paassen J; Stals MAM; Huisman MV; Endeman H
  • Thromb Res 2020[Jul]; 191 (ä): 145-147 PMID32291094show ga
  • INTRODUCTION: COVID-19 may predispose to both venous and arterial thromboembolism due to excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation. Reports on the incidence of thrombotic complications are however not available. METHODS: We evaluated the incidence of the composite outcome of symptomatic acute pulmonary embolism (PE), deep-vein thrombosis, ischemic stroke, myocardial infarction or systemic arterial embolism in all COVID-19 patients admitted to the ICU of 2 Dutch university hospitals and 1 Dutch teaching hospital. RESULTS: We studied 184 ICU patients with proven COVID-19 pneumonia of whom 23 died (13%), 22 were discharged alive (12%) and 139 (76%) were still on the ICU on April 5th 2020. All patients received at least standard doses thromboprophylaxis. The cumulative incidence of the composite outcome was 31% (95%CI 20-41), of which CTPA and/or ultrasonography confirmed VTE in 27% (95%CI 17-37%) and arterial thrombotic events in 3.7% (95%CI 0-8.2%). PE was the most frequent thrombotic complication (n = 25, 81%). Age (adjusted hazard ratio (aHR) 1.05/per year, 95%CI 1.004-1.01) and coagulopathy, defined as spontaneous prolongation of the prothrombin time > 3 s or activated partial thromboplastin time > 5 s (aHR 4.1, 95%CI 1.9-9.1), were independent predictors of thrombotic complications. CONCLUSION: The 31% incidence of thrombotic complications in ICU patients with COVID-19 infections is remarkably high. Our findings reinforce the recommendation to strictly apply pharmacological thrombosis prophylaxis in all COVID-19 patients admitted to the ICU, and are strongly suggestive of increasing the prophylaxis towards high-prophylactic doses, even in the absence of randomized evidence.
  • |Acute Disease[MESH]
  • |Anticoagulants/therapeutic use[MESH]
  • |Arterial Occlusive Diseases/*epidemiology/etiology[MESH]
  • |Brain Ischemia/epidemiology/etiology[MESH]
  • |COVID-19[MESH]
  • |Coronavirus Infections/*complications[MESH]
  • |Critical Illness[MESH]
  • |Embolism/epidemiology/etiology[MESH]
  • |Female[MESH]
  • |Hospitals, Teaching/statistics & numerical data[MESH]
  • |Hospitals, University/statistics & numerical data[MESH]
  • |Humans[MESH]
  • |Incidence[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Myocardial Infarction/epidemiology/etiology[MESH]
  • |Netherlands/epidemiology[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*complications[MESH]
  • |Pulmonary Embolism/*epidemiology/etiology[MESH]
  • |Thrombophilia/drug therapy/*etiology[MESH]
  • |Venous Thrombosis/*epidemiology/etiology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    145 ä.191 2020